Siemens regroups and calls time on big medical technology deals - for the present
This article was originally published in Clinica
Executive Summary
Siemens Medical Solutions finance chief Joe Kaeser has acknowledged that certain recent developments - the relatively sudden purchase of Dade Behring being the major one - had surprised the markets, and led to an ongoing softening of the group's share price. It was trading at below euro90 on August 15 from a 52-week high of over euro112.